McMinn Rachelinsider trades

In SEC Form 4 filings, McMinn Rachel is listed as Chief Executive Officer of Neurogene Inc. (NGNE). McMinn Rachel reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 2.

Companies and roles

Company	Role	Transactions	Last filed
NGNENeurogene Inc.	Chief Executive Officer	2	Oct 2

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-02

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
NGNENeurogene Inc.	Sep 22	Oct 2	M	756	$25.32	$19,142	1,345,063	No	Form 4
NGNENeurogene Inc.	Sep 22	Oct 2	M · derivative	756	$25.32	$19,142	not reported	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.